COVID-19 cases have decreased nationally among healthcare workers from 257 at the beginning of October to 166 towards the end of the month. Out of the more recent cases, 78 cases were reported among vaccinated healthcare workers and 88 among unvaccinated workers.
Appointments are not needed at all Public Health vaccination sites where first, second, and third doses are available.
Los Angeles County health officials again urged eligible residents to get COVID-19 vaccine booster shots, while they also prepared for anticipated federal approval of vaccinations for children aged 5 to 11.
A U.S. Food and Drug Administration advisory panel on Tuesday recommended approval of an emergency use authorization for Pfizer’s COVID-19 vaccine for children as young as 5. FDA officials still need to approve the recommendation, along with a U.S. Centers for Disease Control and Prevention advisory committee and the CDC director.
As the weather changes and the public stays indoors, it’s even more important to consider vaccination according to Public Health
Health officials are making sure staff and eligible recipients receive vaccines and boosters.
Public Health wants patients to have better access to their COVID information and are offering the booster shots at sites offering the Pfizer vaccine.
Los Angeles County’s number of COVID-19-positive hospital patients held mostly steady according to the latest data, increasing by one, while the county reported just five new virus-related deaths. Numbers of new fatalities and COVID infections tend to be low on Mondays due to delays in reporting from the weekend. The five new COVID deaths reported Monday gave the county an overall death toll of 26,018. The county reported another 986 cases, for a pandemic total of 1,455,155.
A Phase 2/3 trial conducted by Pfizer and BioNTech revealed that the Covid-19 vaccine was safe and generated a “robust antibody response” in children ages 5 to 11.
Weekly testing is being recommended for youth 12 and older depending on circumstances.
The Pfizer vaccine is now licensed and approved for prevention of COVID-19.
Earlier this week, the U.S. Food and Drug Administration (FDA) approved the license for the Pfizer-BioNTech COVID-19 vaccine for the prevention of COVID-19 disease for individuals 16 and older. The licensing approval was announced after another thorough evaluation of safety and effectiveness. Muntu Davis, MD, MPH, a Los Angeles County Health Officer, is grateful for the approval and hopes it will ease the minds of those concerned about taking the vaccine.
The U.S. gave full approval to Pfizer’s COVID-19 vaccine Monday, potentially boosting public confidence in the shots and instantly opening the way for more universities, companies and local governments to make vaccinations mandatory. The Pentagon promptly announced it will press ahead with plans to force members of the military to get vaccinated amid the battle against the extra-contagious delta variant. The University of Minnesota likewise said it will require its students get the shot, as did Louisiana’s major public universities, including LSU, though state law there allows broad exemptions. More than 200 million Pfizer doses have been administered in
U.S. health officials Wednesday announced plans to offer COVID-19 booster shots to all Americans to shore up their protection amid the surging delta variant and signs that the vaccines’ effectiveness is falling.
State officials will award $50,000 prizes today to another 15 vaccinated residents as part of a continuing financial-incentive program to encourage inoculations against COVID-19.
According to doctors on the frontlines of the coronavirus pandemic in countries such as Brazil and India – where the global crisis has been most intense.